Bright Minds' BMB-101 Eliminates Seizures And Prevents SUDEP In Mouse Model
13/5 17:05
(RTTNews) - Bright Minds Biosciences (DRUG), Tuesday announced that BMB-101, its selective 5-HT2C Gq-biased agonist, completely abolished drop seizures in the DBA/2 mouse model of epilepsy....